Surface-Enhanced Raman Scattering Biosensors (Volume II)
A special issue of Biosensors (ISSN 2079-6374). This special issue belongs to the section "Optical and Photonic Biosensors".
Deadline for manuscript submissions: 30 January 2025 | Viewed by 1529
Special Issue Editor
Interests: SERS; biosensing; miniaturized devices; PoC devices; clinical applications of SERS; spectral pathology; liquid SERS-based biopsy; SERS based diagnosis; SERS on bacteria
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Like every up-to-date analytical technique with high potential for clinical application, surface-enhanced Raman scattering (SERS) spectroscopy has evolved into a futuristic asset in point-of-care (PoC) analysis. SERS-based biosensing approaches offer promising solutions for the identification of pathogens, rapid testing for viruses, glucose or O2 saturation, antibiotic susceptibility testing, early cancer diagnosis or prognosis, and various other crucial clinical issues. With this Special Issue, we intend to comprehensively collect relevant SERS biosensors studies with potential in PoC testing and off-site use, with a view to improving healthcare accessibility and sustainability.
In this Special Issue, we will also provide the latest input resulting from synergistic approaches like SERS and machine learning, SERS-based spectral pathology enhanced via chemometrics and adaptive, robust computational tools, or SERS-based setups that integrate digital technology for ultrasensitivity and reliability.
Topics of interest to this Special Issue include, but are not limited to, the following:
- Label-free and label-based SERS bioassays;
- Miniaturized SERS-activated platforms for biosensing;
- Data augmentation in spectral pathology and diagnosis;
- Modern and conventional chemometric tools for high-accuracy SERS data analysis;
- Single-cell SERS detection of morphological variations associated with chronic diseases;
- Microfluidic SERS-based devices for clinical use;
- Functional, original SERS-based setups for diagnosis and malignancy monitoring;
- Nanomaterials’ interaction with viable cells for susceptibility testing, drug delivery and efficient treatment.
Dr. Nicoleta Elena Dina
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SERS
- biosensing
- miniaturized devices
- PoC devices
- clinical applications of SERS
- SERS-based diagnosis
